查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621772

穿戴式註射器市场：按类型、技术、应用、最终用途、分销管道划分 - 2025-2030 年全球预测

Wearable Injector Market by Type (Body Worn Patch Injector, Off Body Worn Patch Injector), Technology (Expanding Battery, Motor Driven, Rotary Pump), Application, End-Use, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年穿戴式註射器市值为78.4亿美元，预计到2024年将达到87.1亿美元，复合年增长率为11.26%，到2030年将达到165.6亿美元。

穿戴式註射器是一种创新的药物输送装置，旨在皮下注射大量或黏性药物，主要用于治疗糖尿病、类风湿性关节炎和癌症等慢性疾病。转向以病人为中心的照护、提高依从性和减少医院就诊次数凸显了这项需求。应用涵盖製药和生物技术领域，重点是高风险和慢性疾病的自我管理，减少患者负担和医疗费用。最终使用者主要包括居家照护机构、医疗机构和实验室。关键的成长要素包括慢性病的增加、药物传递技术的进步以及患者对家庭治疗的偏好。先进生技药品、生物相似药和个人化医疗领域存在重大机会，其中数位整合和智慧穿戴式註射器提供即时资料和回馈，以提高患者的依从性。然而，挑战仍然存在，包括严格的法律规范、高昂的开发成本以及有关设备可穿戴性和皮肤刺激的潜在技术问题。为了抓住商机，企业应专注于与高科技公司合作开发智慧解决方案，并优先进行个人化和设备小型化方面的研发，以改善用户体验。对永续性的日益关注也为环保和生物分解性的设备部件打开了大门，为创新创造了一个利润丰厚的领域。从区域来看，新兴国家医疗基础设施的扩张具有巨大的市场渗透潜力。然而，公司必须克服医疗保健法规和支付系统的地区差异。简而言之，这个市场呈现出技术力和策略伙伴关係关係的动态相互作用，需要在利用技术进步和应对监管和消费者挑战方面具有灵活性和远见。透过专注于数位化、针对患者的解决方案并优先考虑永续且具有成本效益的设备开发，公司可以实现显着的业务成长。

主要市场统计
基准年[2023] 78.4亿美元
预计年份 [2024] 87.1亿美元
预测年份 [2030] 165.6亿美元
复合年增长率（%） 11.26%

市场动态：揭示快速发展的可穿戴注射器市场的关键市场洞察

供需的动态交互作用正在改变穿戴式註射器市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病的流行和对先进药物输送设备日益增长的需求
    • 人们越来越偏好微创治疗
  • 市场限制因素
    • 开发穿戴式註射器的高成本
  • 市场机会
    • 穿戴式註射器技术的技术进步
    • 远端医疗解决方案的重要性日益增加
  • 市场挑战
    • 严格核准和监管合规的挑战

波特五力：驾驭穿戴式註射器市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解穿戴式註射器市场的外部影响

外部宏观环境因素在塑造穿戴式註射器市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解穿戴式註射器市场的竞争状况

对穿戴式註射器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵穿戴式註射器市场供应商绩效评估

FPNV定位矩阵是评估穿戴式註射器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划穿戴式註射器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对穿戴式註射器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的增加和对先进药物输送设备的需求不断增长
      • 人们对微创治疗的兴趣日益浓厚
    • 抑制因素
      • 与穿戴式註射器开发相关的高成本
    • 机会
      • 穿戴式註射器技术的技术进步
      • 远端医疗解决方案的重要性日益增加
    • 任务
      • 严格核准和监管合规的挑战
  • 市场区隔分析
    • 类型：越来越多地采用紧凑型贴片注射器
    • 最终用途：可穿戴注射器在居家照护环境中的远端医疗应用中的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章穿戴式註射器市场：依类型

  • 贴片注射器
  • 未配戴在身上的贴片注射器

第七章穿戴式註射器市场：依科技分类

  • 扩充电池
  • 马达驱动
  • 旋转泵
  • 弹簧底座

第八章穿戴式註射器市场：依应用分类

  • 自体免疫疾病
  • 心血管疾病
  • 糖尿病
  • 感染疾病
  • 肿瘤学

第九章穿戴式註射器市场：依最终用途分类

  • 居家照护环境
  • 医院/诊所

第10章可穿戴注射器市场：依通路分类

  • 离线
  • 在线的

第十一章 北美和南美穿戴式註射器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太可穿戴注射器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲穿戴式註射器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准Enable Injections 穿戴式註射器
    • Viridian Therapeutics 宣布与药物传输创新者 Enable Injections 合作
    • LTS 收购 Sorel 的可穿戴注射设备业务
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Amgen Inc.
  • Becton, Dickinson and Company
  • CCBio
  • CeQur Corporation
  • DCA Design International Ltd
  • Debiotech SA
  • E3D Elcam Drug Delivery Devices
  • Enable Injections, Inc.
  • EOFlow Co., Ltd.
  • Gerresheimer AG
  • Insulet Corporation
  • LTS Lohmann Therapie-Systeme AG
  • Medtrum Technologies Inc.
  • Neuma LLC by Kymanox Corporation
  • Noble International LLC by AptarGroup, Inc.
  • NOVO Engineering
  • Shaily Engineering Plastics Ltd.
  • SONCEBOZ SA
  • Stevanato Group SpA
  • Subcuject ApS
  • Viant
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
  • ZwickRoell GmbH & Co. KG
Product Code: MRR-031AB52F47BF

The Wearable Injector Market was valued at USD 7.84 billion in 2023, expected to reach USD 8.71 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 16.56 billion by 2030.

Wearable injectors are innovative drug delivery devices designed to administer large volumes or viscous drugs subcutaneously, catering primarily to chronic disease treatments like diabetes, rheumatoid arthritis, and cancer. Their necessity is underscored by the move towards patient-centric care, enhancing compliance, and reducing hospital visits. The application spans pharmaceuticals and biotech sectors, emphasizing self-administration for high-risk or chronic conditions, thus easing patient burden and healthcare costs. End-users predominantly include home-care settings, healthcare facilities, and research laboratories. Key growth influencers include an increase in chronic diseases, technological advancements in drug delivery, and patient preference for home-based treatments. The market sees considerable opportunity in advanced biologics, biosimilars, and personalized medicine, with digital integration and smart wearable injectors offering real-time data and feedback, improving patient adherence. However, challenges persist, such as stringent regulatory frameworks, high development costs, and potential technical issues with device wearability and skin irritation. To capitalize on opportunities, businesses should focus on collaborations with tech firms for smart solutions, and prioritize R&D in personalization and miniaturization of devices to enhance user experience. The growing emphasis on sustainability also opens doors for eco-friendly, biodegradable device components, presenting a lucrative innovation area. Geographically, the expanding healthcare infrastructure in emerging economies holds significant potential for market penetration. However, companies must navigate regional variations in healthcare regulations and payer systems. In essence, the market presents a dynamic interplay of technological prowess and strategic partnerships, demanding agility and foresight in leveraging technological advancements and addressing regulatory and consumer challenges. Through focusing on digitally-enhanced, patient-specific solutions, and prioritizing sustainable and cost-effective device development, companies can achieve substantial business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 7.84 billion
Estimated Year [2024] USD 8.71 billion
Forecast Year [2030] USD 16.56 billion
CAGR (%) 11.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wearable Injector Market

The Wearable Injector Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic diseases and high need for advanced drug delivery device
    • Rising preferences for minimally invasive treatments
  • Market Restraints
    • High costs associated with wearable injector development
  • Market Opportunities
    • Technological advancements in wearable injector technology
    • Growing significance of telehealth solutions
  • Market Challenges
    • Challenges associated with strigent approval and regulatory compliances

Porter's Five Forces: A Strategic Tool for Navigating the Wearable Injector Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wearable Injector Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wearable Injector Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wearable Injector Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wearable Injector Market

A detailed market share analysis in the Wearable Injector Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wearable Injector Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wearable Injector Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wearable Injector Market

A strategic analysis of the Wearable Injector Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wearable Injector Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Becton, Dickinson and Company, CCBio, CeQur Corporation, DCA Design International Ltd, Debiotech SA, E3D Elcam Drug Delivery Devices, Enable Injections, Inc., EOFlow Co., Ltd., Gerresheimer AG, Insulet Corporation, LTS Lohmann Therapie-Systeme AG, Medtrum Technologies Inc., Neuma LLC by Kymanox Corporation, Noble International LLC by AptarGroup, Inc., NOVO Engineering, Shaily Engineering Plastics Ltd., SONCEBOZ SA, Stevanato Group S.p.A., Subcuject ApS, Viant, West Pharmaceutical Services, Inc., Ypsomed Holding AG, and ZwickRoell GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Wearable Injector Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Body Worn Patch Injector and Off Body Worn Patch Injector.
  • Based on Technology, market is studied across Expanding Battery, Motor Driven, Rotary Pump, and Spring-based.
  • Based on Application, market is studied across Autoimmune Disease, Cardiovascular Disease, Diabetes, Infectious Disease, and Oncology.
  • Based on End-Use, market is studied across Home Care Setting and Hospitals & Clinics.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases and high need for advanced drug delivery device
      • 5.1.1.2. Rising preferences for minimally invasive treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with wearable injector development
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in wearable injector technology
      • 5.1.3.2. Growing significance of telehealth solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges associated with strigent approval and regulatory compliances
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Types: Rising adoption for compact body worn patch injector
    • 5.2.2. End-Use: Growing significance of wearable injectors in telehealth applications in home care settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wearable Injector Market, by Type

  • 6.1. Introduction
  • 6.2. Body Worn Patch Injector
  • 6.3. Off Body Worn Patch Injector

7. Wearable Injector Market, by Technology

  • 7.1. Introduction
  • 7.2. Expanding Battery
  • 7.3. Motor Driven
  • 7.4. Rotary Pump
  • 7.5. Spring-based

8. Wearable Injector Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Disease
  • 8.3. Cardiovascular Disease
  • 8.4. Diabetes
  • 8.5. Infectious Disease
  • 8.6. Oncology

9. Wearable Injector Market, by End-Use

  • 9.1. Introduction
  • 9.2. Home Care Setting
  • 9.3. Hospitals & Clinics

10. Wearable Injector Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Wearable Injector Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Wearable Injector Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Wearable Injector Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. FDA Approves Enable Injections' Wearable Injector
    • 14.3.2. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
    • 14.3.3. LTS Acquires Sorrel Wearable Injection Device Business
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Amgen Inc.
  • 3. Becton, Dickinson and Company
  • 4. CCBio
  • 5. CeQur Corporation
  • 6. DCA Design International Ltd
  • 7. Debiotech SA
  • 8. E3D Elcam Drug Delivery Devices
  • 9. Enable Injections, Inc.
  • 10. EOFlow Co., Ltd.
  • 11. Gerresheimer AG
  • 12. Insulet Corporation
  • 13. LTS Lohmann Therapie-Systeme AG
  • 14. Medtrum Technologies Inc.
  • 15. Neuma LLC by Kymanox Corporation
  • 16. Noble International LLC by AptarGroup, Inc.
  • 17. NOVO Engineering
  • 18. Shaily Engineering Plastics Ltd.
  • 19. SONCEBOZ SA
  • 20. Stevanato Group S.p.A.
  • 21. Subcuject ApS
  • 22. Viant
  • 23. West Pharmaceutical Services, Inc.
  • 24. Ypsomed Holding AG
  • 25. ZwickRoell GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. WEARABLE INJECTOR MARKET RESEARCH PROCESS
  • FIGURE 2. WEARABLE INJECTOR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. WEARABLE INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. WEARABLE INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WEARABLE INJECTOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WEARABLE INJECTOR MARKET DYNAMICS
  • TABLE 7. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY EXPANDING BATTERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY MOTOR DRIVEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ROTARY PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPRING-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. WEARABLE INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. WEARABLE INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023